# Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use

> **NCT04811508** · — · COMPLETED · sponsor: **Centre Hospitalier le Mans** · enrollment: 172 (actual)

## Conditions studied

- Relapsed Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04811508
- **Lead sponsor:** Centre Hospitalier le Mans
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811508, "Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04811508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*